With a market capitalization (market cap) of $3.82B — a measure of how much the company is worth — Envista Holdings Corp ranks #1,559 among the 2,510 companies tracked, and 182nd in Healthcare as of October 3, 2026. Shares trade at $23.46, up 1.30% on the day.
of 2,510 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series — they can diverge when the share count changes. Those returns are not a CAGR until you pick a start value, an ending value, and years. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation October 2, 2026. Ranking headline cap is the snapshot figure as of October 3, 2026.
| Year | As of | Market cap | Annual change | Year-end close |
|---|---|---|---|---|
| 2026 | Oct 2, 2026 | $3.8B | +6.74% | $23.46 |
| 2025 | Dec 31, 2025 | $3.56B | +7.00% | $21.71 |
| 2024 | Dec 31, 2024 | $3.33B | -19.50% | $19.29 |
| 2023 | Dec 29, 2023 | $4.13B | -24.87% | $24.06 |
| 2022 |
Ranking figure $3.82B as of October 3, 2026.
Envista Holdings Corp's ranking market cap is the provider-reported capitalization on the same snapshot as the rest of this site, with a share price of $23.46 as of October 2, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $3.8B on October 2, 2026. See how the ranking works.
Live shares outstanding are not on the quote used for price, so this page does not invent a current share count. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 168,000,000 shares. That figure is an average for the year, not the live count in the market-cap formula.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Not in this snapshot
FY 2025 net worth
Largest U.S.-listed names in the same FMP sector — not a hand-picked competitor set.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #14 | Eli Lilly and Company LLY | $1.08T | -0.61% |
| #21 | Johnson & Johnson JNJ | $617.01B | -1.02% |
| #24 |
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of October 3, 2026, Envista Holdings Corp (NVST) is worth $3.82B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, Envista Holdings Corp’s book equity is about $3.11B. Market cap is the market value of the outstanding shares. As of October 3, 2026, its market cap is $3.82B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Envista Holdings Corp ranks #1,559 among the 2,510 companies tracked on MarketCapLens. In Healthcare it ranks #182 of 350.
Fundamentals are annual. Figures labeled with their fiscal year. Live ratios use the current price against those annual earnings.
| Dec 30, 2022 |
| $5.5B |
| -36.46% |
| $33.67 |
| 2021 | Dec 31, 2021 | $8.65B | — | $45.06 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Not in this snapshot
FY 2025
| $464.35B |
| +1.11% |
| #36 | Merck & Co., Inc. MRK | $356.4B | +0.34% |
| #38 | UnitedHealth Group Incorporated UNH | $337.74B | +1.83% |
| #52 | Novartis AG NVS | $268B | -0.04% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #1556 | CorVel Corporation CRVL | $3.85B | +1.00% |
| #1557 | Firefly Aerospace Inc. FLY | $3.83B | +2.06% |
| #1558 | SkyWest, Inc. SKYW | $3.82B | -1.29% |
| #1560 | DHT Holdings, Inc. DHT | $3.81B | +0.51% |
| #1561 | Wix.com Ltd. WIX | $3.81B | -1.00% |
| #1562 | COPT Defense Properties CDP | $3.81B | +0.90% |
Envista Holdings Corp’s ranking market cap of $3.82B comes from the same snapshot as the rest of this site, as of October 3, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 168,000,000. The historical market-cap series last observed $3.8B on October 2, 2026.
Over the past year, Envista Holdings Corp’s market cap is up 12.32%, using historical market-cap records rather than today’s share count applied to past prices.
Envista Holdings Corp (NVST) shares trade at $23.46, up 1.30% on the day, as of October 3, 2026.
Envista Holdings Corp trades at a live price-to-earnings (P/E) ratio of 83.8, using the latest share price divided by the latest annual earnings per share. That is not the same as a fiscal-year reported P/E.